Alkermes to Take Part in 41st Annual Goldman Sachs Global Healthcare Conference

DUBLIN, June 4, 2020 /PRNewswire/ -- Alkermes plc ALKS announced today that management will participate in a fireside chat at the 41^st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2020 at 9:40 a.m. ET (2:40 p.m. BST). The webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:

Alex Braun

Investor Relations

+1 781 296 8493

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-41st-annual-goldman-sachs-global-healthcare-conference-301070832.html

SOURCE Alkermes plc